Figure 2.
Figure 2. Five-year event-free survival (EFS) according to the type of postinduction intensification (PII) chemotherapy for higher risk acute lymphoblastic leukemia (ALL) patients.23. / Reprinted with permission from Seibel NL, Steinherz PG, Sather HN, et al. Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children’s Oncology Group. Blood. 2008;111:2548–2555. © the American Society of Hematology

Five-year event-free survival (EFS) according to the type of postinduction intensification (PII) chemotherapy for higher risk acute lymphoblastic leukemia (ALL) patients.23

Reprinted with permission from

Seibel NL, Steinherz PG, Sather HN, et al. Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children’s Oncology Group. Blood. 2008;111:2548–2555.
© the American Society of Hematology

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal